Veracyte Inc
SWB:12V
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Veracyte Inc (12V) under the Base Case is EUR per share.
Compared with the current market price of 21.61 EUR, the stock appears .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Veracyte Does
Veracyte is a molecular diagnostics company that makes lab tests doctors use to help diagnose cancer and other serious diseases. Its tests analyze genetic and other biological signals from patient samples, such as tissue or blood, to give more useful answers than traditional methods alone. The company sells these tests to hospitals, doctors, and labs that need better information to guide care.
- Headquarters
- United States of America US
- Employees
- 755
- IPO date
- Oct 30, 2013
Ownership
Veracyte insiders are selling more than usual
Insiders sell for many reasons, such as taxes or planned sales; purchases are rarer.
Continue 12V Research
Decided on Veracyte? Get an email when 12V reaches the price you’d buy at. Free with an account.
Other Veracyte listings
What is the Intrinsic Value of one 12V stock?
The intrinsic value for
Veracyte Inc (12V) under the Base Case is EUR.
Is 12V stock undervalued or overvalued?
Compared with the current market price of 21.61 EUR, the stock appears .